X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2055) 2055
Book Review (386) 386
Publication (146) 146
Book / eBook (27) 27
Book Chapter (7) 7
Conference Proceeding (7) 7
Dissertation (3) 3
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1917) 1917
humans (1877) 1877
male (1143) 1143
female (1096) 1096
aged (815) 815
intracranial hemorrhages - chemically induced (805) 805
middle aged (769) 769
anticoagulants - adverse effects (624) 624
clinical neurology (621) 621
stroke (499) 499
risk factors (497) 497
adult (486) 486
intracranial hemorrhage (478) 478
treatment outcome (426) 426
aged, 80 and over (393) 393
warfarin (358) 358
abridged index medicus (355) 355
peripheral vascular disease (355) 355
hemorrhage (352) 352
cerebral hemorrhage - chemically induced (346) 346
retrospective studies (308) 308
warfarin - adverse effects (296) 296
hemorrhage - chemically induced (294) 294
fibrinolytic agents - adverse effects (290) 290
intracerebral hemorrhage (273) 273
neurosciences (270) 270
therapy (269) 269
anticoagulants (261) 261
anticoagulants - therapeutic use (260) 260
risk (259) 259
time factors (256) 256
animals (252) 252
neurology (243) 243
surgery (243) 243
stroke - drug therapy (234) 234
tissue plasminogen activator - adverse effects (215) 215
tomography, x-ray computed (215) 215
anticoagulants - administration & dosage (210) 210
management (205) 205
thrombolytic therapy - adverse effects (204) 204
mortality (199) 199
brain (186) 186
medicine, general & internal (179) 179
stroke - prevention & control (178) 178
risk assessment (174) 174
atrial fibrillation - drug therapy (173) 173
cardiac & cardiovascular systems (172) 172
atrial fibrillation (170) 170
platelet aggregation inhibitors - adverse effects (169) 169
medicine & public health (166) 166
administration, oral (158) 158
brain ischemia - drug therapy (157) 157
stroke - etiology (157) 157
care and treatment (153) 153
hematology (153) 153
thrombolysis (149) 149
fibrinolytic agents - therapeutic use (147) 147
international normalized ratio (146) 146
atrial-fibrillation (143) 143
atrial fibrillation - complications (142) 142
fibrinolytic agents - administration & dosage (142) 142
aspirin (139) 139
anticoagulation (132) 132
subarachnoid hemorrhage (132) 132
dabigatran (131) 131
adolescent (130) 130
tissue plasminogen activator - administration & dosage (130) 130
prospective studies (127) 127
prevention (125) 125
intracranial hemorrhages - epidemiology (124) 124
magnetic resonance imaging (117) 117
thrombolytic therapy (117) 117
acute ischemic-stroke (116) 116
analysis (115) 115
warfarin - therapeutic use (112) 112
ischemia (111) 111
drug therapy (109) 109
safety (106) 106
aspirin - adverse effects (104) 104
tissue-plasminogen activator (104) 104
thrombosis (102) 102
follow-up studies (100) 100
dose-response relationship, drug (99) 99
tissue plasminogen activator - therapeutic use (99) 99
cerebral angiography (98) 98
cohort studies (98) 98
incidence (98) 98
cardiovascular (96) 96
health aspects (96) 96
rats (96) 96
complications and side effects (95) 95
disease models, animal (95) 95
critical care medicine (94) 94
drug therapy, combination (93) 93
platelet aggregation inhibitors - therapeutic use (93) 93
internal medicine (92) 92
research (91) 91
tissue plasminogen activator (91) 91
age factors (90) 90
odds ratio (90) 90
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (19) 19
Baycrest Hospital - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1947) 1947
German (35) 35
French (30) 30
Spanish (25) 25
Japanese (13) 13
Russian (9) 9
Turkish (5) 5
Danish (4) 4
Chinese (3) 3
Hungarian (3) 3
Italian (3) 3
Swedish (3) 3
Dutch (2) 2
Polish (2) 2
Bulgarian (1) 1
Czech (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 1, pp. 9 - 19
In patients with acute coronary syndromes, low doses of rivaroxaban were effective in reducing the primary end point of death from cardiovascular causes,... 
ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | PLACEBO | EVENTS | MYOCARDIAL-INFARCTION | SAFETY | DOUBLE-BLIND | THROMBOPROPHYLAXIS | APIXABAN | FACTOR XA INHIBITOR | ANTIPLATELET THERAPY | Thiophenes - therapeutic use | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hemorrhage - mortality | Male | Secondary Prevention | Thiophenes - administration & dosage | Incidence | Rivaroxaban | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Drug Administration Schedule | Morpholines - administration & dosage | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Acute Coronary Syndrome - drug therapy | Intracranial Hemorrhages - chemically induced | Aged | Hemorrhage - chemically induced | Drugs | Dose-response relationship (Biochemistry) | Dosage and administration | Product/Service Evaluations | Drug therapy | Coronary heart disease | Myocardial infarction | Cerebral infarction | Anticoagulants | Heart attacks | Arteriosclerosis | Cardiovascular disease | Death | Angina pectoris | Hemorrhage | Thrombosis | Bleeding | Index Medicus | Abridged Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 131, Issue 2, pp. 157 - 164
Background-The comparative safety of dabigatran versus warfarin for treatment of nonvalvular atrial fibrillation in general practice settings has not been... 
anticoagulant | thrombin inhibitor | safety | pharmacoepidemiology | warfarin | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | ADMINISTRATIVE DATA | VALIDATION | OLDER | CODING ACCURACY | STROKE | THERAPY | ACUTE MYOCARDIAL-INFARCTION | PERIPHERAL VASCULAR DISEASE | POSITIVE PREDICTIVE-VALUE | Anticoagulants - administration & dosage | Follow-Up Studies | United States | Humans | Medicare - statistics & numerical data | Warfarin - adverse effects | Risk | Dabigatran | Gastrointestinal Hemorrhage - epidemiology | Socioeconomic Factors | Warfarin - therapeutic use | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Kidney Diseases - epidemiology | Aged, 80 and over | Retrospective Studies | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Benzimidazoles - therapeutic use | Stroke - prevention & control | beta-Alanine - adverse effects | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Comorbidity | Atrial Fibrillation - complications | Kaplan-Meier Estimate | Proportional Hazards Models | beta-Alanine - administration & dosage | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Anticoagulants - adverse effects | Gastrointestinal Hemorrhage - chemically induced | Stroke - etiology | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Complications and side effects | Warfarin | Atrial fibrillation | Aged patients | Dabigatran etexilate | Dosage and administration | Comparative analysis | Drug therapy | Health aspects | Hemorrhage | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 12, pp. 1131 - 1141
Journal Article
Journal Article
Stroke, ISSN 0039-2499, 06/2012, Volume 43, Issue 6, pp. 1511 - 1517
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article